Human Longevity: Funding, Investors & Team (Sep 2026)
Human Longevity (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. Its business areas include the HLI Health Nucleus, a genomic powered clinical research center that uses whole-genome sequence analysis, advanced clinical imaging, and innovative machine learning, along with curated personal health information to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. It was founded in 2013 and is headquartered in San Diego, California.
Human Longevity has raised $50.3M across 2 funding rounds on record, the most recent a Series B of $39.8M announced in Aug 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Human Longevity Company Profile and Key Stats
Latest funding round on record: Aug 2024.
Human Longevity Funding Rounds
Human Longevity raised $10.5M in an undisclosed round announced in Apr 2023.
1.3 years later, a Series B of $39.8M was announced in Aug 2024.
Human Longevity Founders and Leadership Team
No contact details are on record for this team yet.
Human Longevity Funding Compared to Other Biotechnology Startups
Human Longevity's latest round of $39.8M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Human Longevity in Biotechnology and San Diego
Companies Similar to Human Longevity
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Human Longevity Funding FAQs
What does Human Longevity do?
Human Longevity (HLI) is the genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived. HLI combines the largest database of genomic and phenotypic data with machine learning to drive discoveries and revolutionize the practice of medicine. Its business areas include the HLI Health Nucleus, a genomic powered clinical research center that uses whole-genome sequence analysis, advanced clinical imaging, and innovative machine learning, along with curated personal health information to deliver the most complete picture of individual health; HLIQ Whole Genome and HLIQ Oncology. It was founded in 2013 and is headquartered in San Diego, California.
How much funding has Human Longevity raised?
Human Longevity has raised $50.3M across 2 rounds on record. The most recent is a Series B of $39.8M announced in Aug 2024.
When did Human Longevity last raise funding?
Human Longevity's most recent funding round on record is a Series B of $39.8M, announced in Aug 2024.
Who founded Human Longevity?
FundedIQ lists Elizabeth Hunker (Founder) at Human Longevity.
Who is the CEO of Human Longevity?
Cynthia Colllins is listed as CEO at Human Longevity.
Where is Human Longevity headquartered?
Human Longevity is based in San Diego, California, United States.
How many employees does Human Longevity have?
Human Longevity is in the 101-250 employee band.
How does Human Longevity's funding compare to other Biotechnology startups?
Human Longevity's latest round of $39.8M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Human Longevity Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Human Longevity is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.